Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.
about
Interventions for treating intrahepatic cholestasis in people with sickle cell diseaseMechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG).Circulating membrane-derived microvesicles in redox biology.Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia.Emerging science of hydroxyurea therapy for pediatric sickle cell disease.Extracellular vesicles in hematological disorders.Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes.Microparticles in sickle cell anaemia: promise and pitfalls.Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges.Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.Decrease of externalized phosphatidylserine density on red blood cell-derived microparticles in SCA patients treated with hydroxycarbamide.Applicability of extracellular vesicles in clinical studies.Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients.
P2860
Q24200803-0F37671C-5816-440C-83CF-4F2683270AEFQ33422771-B5F75C46-9158-46C4-A1F2-23E30A7652E0Q35737756-E112344E-5CC0-401C-AAB8-3C15570D19A9Q36368068-C7E61CC1-4510-4381-B571-AB09D52322B1Q37033939-3974DAF6-EE6D-4185-8DF7-BEF50823C143Q37514497-07EF145F-8E68-4F0F-8240-125B881694EBQ38164192-8F213F58-1887-465D-9EE6-2AC3AABFD92FQ38266903-20F528F7-D035-41B7-8904-55EA85EDADDAQ38772122-1B72882C-6807-4F93-866E-54961D2A764FQ38823104-5D355A0E-F002-4D42-9571-35A5F5F00F14Q38837694-C4E9FD0B-33BA-4617-9704-EAD4A5E8D5DBQ39094303-658DF4E2-984D-49C4-89FA-0C2F85F46C6FQ43111402-C1AE66FA-D27B-49E0-AB13-E417CC907D6FQ48219007-624FC854-BA28-443D-9F72-DD12071D8D6EQ48280242-39C6D97E-315E-4A14-91D0-2D48C0120999Q49741768-A25CABD3-7501-4FA2-91C6-255A43AC869FQ50442869-A2B60F20-45B1-4050-95CD-65C9586AF840Q53396661-95F99E3E-14E3-43FE-904A-9BE77847B8C2
P2860
Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Fetal hemoglobin and hydroxyca ...... n sickle cell anemia children.
@en
type
label
Fetal hemoglobin and hydroxyca ...... n sickle cell anemia children.
@en
prefLabel
Fetal hemoglobin and hydroxyca ...... n sickle cell anemia children.
@en
P2093
P2860
P1433
P1476
Fetal hemoglobin and hydroxyca ...... n sickle cell anemia children.
@en
P2093
Cédric Broquere
Danitza Nébor
Jacques Elion
Julien Picot
Lydia Doumdo
Malika Benkerrou
Marc Romana
Marie-Hélène Odièvre
Nathalie Vachiery
Raoul Santiago
P2860
P304
P356
10.3324/HAEMATOL.2012.073619
P577
2013-02-12T00:00:00Z